李云峰,周世强,史喜德,李飞

• 1:中国人民解放军空军军医大学第一附属医院心血管内科
• 2:天水市第一人民医院心血管内科

摘要(Abstract)：

脑卒中作为经导管主动脉瓣置换术（TAVR）最严重并发症之一，显著增加患者神经认知功能下降和死亡的风险。随着TAVR的适应证进一步扩展到外科低风险患者群体，脑卒中的防治至关重要。近年来多种脑栓塞保护装置（CEPD）被用于过滤或偏转去往脑循环的栓塞碎片，已成为预防脑卒中的一种选择，因此亟需了解CEPD在预防脑卒中的作用及适用群体，然而，目前TAVR相关脑卒中的风险因素以及常规使用CEPD的证据尚存在争议。本文就TAVR相关脑卒中及CEPD的研究证据进行综述，并概述了这一领域的最新进展。

关键词(KeyWords)： 主动脉瓣狭窄;脑栓塞保护;脑卒中;经导管主动脉瓣置换术

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金项目（82170250）

作者(Author): 李云峰,周世强,史喜德,李飞

参考文献(References)：

• [1]Khanji MY,Ricci F,Galusko V,et al.Management of aortic stenosis:a systematic review of clinical practice guidelines and recommendations[J].Eur Heart J Qual Care Clin Outcomes,2021,7(4):340-353.DOI:10.1093/ehjqcco/qcab016.
• [2]Muralidharan A,Thiagarajan K,Van Ham R,et al.Metaanalysis of perioperative stroke and mortality in transcatheter aortic valve implantation[J].Am J Cardiol,2016,118(7):1031-1045.DOI:10.1016/j.amjcard.2016.07.011.
• [3]Mack MJ,Leon MB,Thourani VH,et al.Transcatheter aortic-valve replacement with a balloon-expandable valve in lowrisk patients[J].N Engl J Med,2019,380(18):1695-1705.DOI:10.1056/NEJMoa1814052.
• [4]Popma JJ,Deeb GM,Yakubov SJ,et al.Transcatheter aorticvalve replacement with a self-expanding valve in low-risk patients[J].N Engl J Med,2019,380(18):1706-1715.DOI:10.1056/NEJMoa1816885.
• [5]中国医师协会心血管内科医师分会结构性心脏病专业委员会.中国经导管主动脉瓣置换术临床路径专家共识(2021版)[J].中国介入心脏病学杂志,2022,30(1):7-16.DOI:10.3969/j.issn.1004-8812.2022.01.002.
• [6]Carroll JD,Vemulapalli S,Dai D,et al.Procedural experience for transcatheter aortic valve replacement and relation to outcomes:the STS/ACC TVT registry[J].J Am Coll Cardiol,2017,70(1):29-41.DOI:10.1016/j.jacc.2017.04.056.
• [7]Kapadia S,Agarwal S,Miller DC,et al.Insights into timing,risk factors,and outcomes of stroke and transient ischemic attack after transcatheter aortic valve replacement in the PARTNER trial(Placement of Aortic Transcatheter Valves)[J].Circ Cardiovasc Interv,2016,9(9):e002981.DOI:10.1161/CIRCINTERVENTIONS.115.002981.
• [8]谭冠昶,李炜杰,李捷,等.经导管主动脉瓣置换术过程中使用Sentinel脑保护装置的效果和安全性分析[J].中国介入心脏病学杂志,2023,31(10):741-746.DOI:10.3969/j.issn.1004-8812.2023.10.004.
• [9]Butala NM,Makkar R,Secemsky EA,et al.Cerebral embolic protection and outcomes of transcatheter aortic valve replacement:results from the transcatheter valve therapy registry[J].Circulation,2021,143(23):2229-2240.DOI:10.1161/CIRCULATIONAHA.120.052874.
• [10]Genereux P,Piazza N,Alu MC,et al.Valve Academic Research Consortium 3:updated endpoint definitions for aortic valve clinical research[J].Eur Heart J,2021,42(19):1825-1857.DOI:10.1093/eurheartj/ehaa799.
• [11]Meertens MM,Macherey S,Asselberghs S,et al.A systematic review and meta-analysis of the cerebrovascular event incidence after transcatheter aortic valve implantation[J].Clin Res Cardiol,2022,111(8):843-858.DOI:10.1007/s00392-022-01997-1.
• [12]Huded CP,Tuzcu EM,Krishnaswamy A,et al.Association between transcatheter aortic valve replacement and early postprocedural stroke[J].JAMA,2019,321(23):2306-2315.DOI:10.1001/jama.2019.7525.
• [13]Richter I,Abdel-Wahab M,Desch S,et al.Cerebral embolic protection in patients undergoing transcatheter aortic valve implantation:recent advances[J].Kardiol Pol,2022,80(6):644-650.DOI:10.33963/KP.a 2022.0118.
• [14]Kahlert P,Al-Rashid F,D?ttger P,et al.Cerebral embolization during transcatheter aortic valve implantation:a transcranial Doppler study[J].Circulation,2012,126(10):1245-125 5.DOI:10.1161/CIRCULATIONAHA.112.092544.
• [15]Erdoes G,Basciani R,Huber C,et al.Transcranial Dopplerdetected cerebral embolic load during transcatheter aortic valve implantation[J].Eur J Cardiothorac Surg,2012,41(4):778-783,783-784.DOI:10.1093/ejcts/ezr068.
• [16]Muntane-Carol G,Urena M,Munoz-Garcia A,et al.Late cerebrovascular events following transcatheter aortic valve replacement[J].JACC Cardiovasc Interv,2020,13(7):872-881.DOI:10.1016/j.jcin.2019.11.022.
• [17]Bjursten H,Norrving B,Ragnarsson S.Late stroke after transcatheter aortic valve replacement:a nationwide study[J].Sci Rep,2021,11(1):9593.DOI:10.1038/s41598-021-89217-0.
• [18]Van Mieghem NM,Schipper ME,Ladich E,et al.Histopathology of embolic debris captured during transcatheter aortic valve replacement[J].Circulation,2013,127(22):2194-2201.DOI:10.1161/CIRCULATIONAHA.112.001091.
• [19]Van Mieghem NM,El Faquir N,Rahhab Z,et al.Incidence and predictors of debris embolizing to the brain during transcatheter aortic valve implantation[J].JACC Cardiovasc Interv,2015,8(5):718-724.DOI:10.1016/j.jcin.2015.01.020.
• [20]Kapadia SR,Kodali S,Makkar R,et al.Protection against cerebral embolism during transcatheter aortic valve replacement[J].J Am Coll Cardiol,2017,69(4):367-377.DOI:10.1016/j.jacc.2016.10.023.
• [21]Kroon H,von der Thusen JH,Ziviello F,et al.Heterogeneity of debris captured by cerebral embolic protection filters during TAVI[J].EuroIntervention,2021,16(14):1141-1147.DOI:10.4244/EIJ-D-20-00744.
• [22]Seeger J,Virmani R,Romero M,et al.Significant differences in debris captured by the sentinel dual-filter cerebral embolic protection during transcatheter aortic valve replacement among different valve types[J].JACC Cardiovasc Interv,2018,11(17):1683-1693.DOI:10.1016/j.jcin.2018.06.018.
• [23]Schmidt T,Leon MB,Mehran R,et al.Debris heterogeneity across different valve types captured by a cerebral protection system during transcatheter aortic valve replacement[J].JACC Cardiovasc Interv,2018,11(13):1262-1273.DOI:10.1016/j.jcin.2018.03.001.
• [24]De Backer O,Butt JH,Wong YH,et al.Early and late risk of ischemic stroke after TAVR as compared to a nationwide background population[J].Clin Res Cardiol,2020,109(7):791-801.DOI:10.1007/s00392-019-01565-0.
• [25]Thourani VH,O'Brien SM,Kelly JJ,et al.Development and application of a risk prediction model for in-hospital stroke after transcatheter aortic valve replacement:a report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry[J].Ann Thorac Surg,2019,107(4):1097-1103.DOI:10.1016/j.athoracsur.2018.11.013.
• [26]Berkovitch A,Segev A,Maor E,et al.Clinical predictors for procedural stroke and implications for embolic protection devices during TAVR:results from the multicenter transcatheter aortic valve replacement in-hospital stroke(TASK)study[J].J Pers Med,2022,12(7):1056.DOI:10.3390/jpm12071056.
• [27]Ciobanu AO,Gherasim L,Vinereanu D.Risk of stroke after transcatheter aortic valve implantation:epidemiology,mechanism,and management[J].Am J Ther,2021,28(5):e560-e572.DOI:10.1097/MJT.0000000000001413.
• [28]Seppelt PC,Mas-Peiro S.De Rosa R,et al.Thirty-day incidence of stroke after transfemoral transcatheter aortic valve implantation:meta-analysis and mixt-treatment comparison of self-expandable versus balloon-expandable valve prostheses[J].Clin Res Cardiol,2021,110(5):640-648.DOI:10.1007/s00392-020-01775-x.
• [29]Fink N,Segev A,Kornowski R,et al.Balloon dilatation and outcome among patients undergoing trans-femoral aortic valve replacement[J].Int J Cardiol,2017,230:537-541.DOI:10.1016/j.ijcard.2016.12.062.
• [30]Wang B,Mei Z,Ge X,et al.Comparison of outcomes of self-expanding versus balloon-expandable valves for transcatheter aortic valve replacement:a meta-analysis of randomized and propensity-matched studies[J].BMC Cardiovasc Disord,2023,23(1):382.DOI:10.1186/s12872-023-03397-3.
• [31]Saeed Al-Asad K,Martinez Salazar A,Radwan Y,et al.Transcatheter aortic valve replacement in bicuspid versus tricuspid aortic valve stenosis:meta-analysis and systemic review[J].Am J Cardiol,2023,203:105-112.DOI:10.1016/j.amjcard.2023.06.120.
• [32]Fan J,Fang X,Liu C,et al.Brain injury after transcatheter replacement of bicuspid versus tricuspid aortic valves[J].J Am Coll Cardiol,2020,76(22):2579-2590.DOI:10.1016/j.jacc.2020.09.605.
• [33]Haussig S,Mangner N,Dwyer MG,et al.Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis:the CLEAN-TAVI randomized clinical trial[J].JAMA,2016,316(6):592-601.DOI:10.1001/jama.2016.10302.
• [34]Van Mieghem NM,van Gils L,Ahmad H,et al.F ilter-based cerebral embolic protection with transcatheter aortic valve implantation:the randomised MISTRAL-C trial[J].EuroIntervention,2016,12(4):499-507.DOI:10.4244/EIJV12I4A84.
• [35]Megaly M,Sorajja P,Cavalcante JL,et al.Ischemic stroke with cerebral protection system during transcatheter aortic valve replacement[J].JACC Cardiovasc Interv,2020,13(18):2149-2155.DOI:10.1016/j.j cin.2020.05.039.
• [36]Kapadia SR,Makkar R,Leon M,et al.Cerebral embolic protection during transcatheter aortic-valve replacement[J].N Engl J Med,2022,387(14):1253-1263.DOI:10.1056/NEJMoa2204961.
• [37]Kharhanda RK,Perkins AD,Kennedy J,et al.Routine cerebral embolic protection in transcatheter aortic valve implantation:rationale and design of the randomised British Heart Foundation PROTECT-TAVI trial[J].Euro Intervention,2023,18(17):1428-1435.DOI:10.4244/EIJ-D-22-00713.
• [38]Lansky AJ,Schofer J,Tchetche D,et al.A prospective randomized evaluation of the TriGuard~(TM)HDH embolic DEFLECTION device during transcatheter aortic valve implantation:results from the DEFLECTⅢtrial[J].Eur Heart J,2015,36(31):2070-2078.DOI:10.1093/eurheartj/ehv191.
• [39]Lansky AJ,Makkar R,Nazif T,et al.A randomized evaluation of the TriGuard~(TM)HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation:the REFLECT I trial[J].Eur Heart J,2021,42(27):2670-2679.DOI:10.1093/eurheartj/ehab213.
• [40]Nazif TM,Moses J,Sharma R,et al.Randomized evaluation of TriGuard 3 cerebral embolic protection after transcatheter aortic valve replacement:REFLECTⅡ[J].JACC Cardiovasc Interv,2021,14(5):515-527.DOI:10.1016/j.jcin.2020.11.011.
• [41]Latib A,Mangieri A,Vezzulli P,et al.First-inman study evaluating the emblok embolic protection system duringtranscatheter aortic valve replacement[J].JACC Cardiovasc Inteiv,2020,13(7):860-868.DOI:10.1016/j.jcin.2019.11.017.
• [42]Pasupati S.TCT CONNECT-458 Clinical performance of a total embolic protection device:results of the Emboliner SafePass 2 study[J/OL].J Am Coll Cardiol,2020,76(17,Supplement):B196.DOI:https://doi.org/10.1016/j.jacc.2020.09.487.
• [43]Ahmad Y,Howard JP.Meta-Analysis of Usefulness of cerebral embolic protection during transcatheter aortic valve implantation[J].Am J Cardiol,2021,146:69-73.DOI:10.1016/j.amjcard.2021.01.023.
• [44]Baloch ZQ,Haider SJ,Siddiqui HF,et al.Utility of cerebral embolic protection devices in transcatheter procedures:a systematic review and meta-analysis[J].Curr Probl Cardiol,2023,48(7):101675.DOI:10.1016/j.cpcardiol.2023.101675.
• [45]Woldendorp K,Indja B,Bannon PG,et al.Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation:a systematic review and meta-analysis[J].Eur Heart J,2021,42(10):1004-1015.DOI:10.1093/eurheartj/ehab002.
• [46]Jagielak D,Targonski R,Frerker C,et al.Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation:the PROTEMBO C trial[J].Euro Intervention,2022,18(7):590-597.DOI:10.4244/EIJ-D-22-00238.
• [47]Rodes-Cabau J,Kahlert P,Neumann FJ,et al.Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cereb ral emboli in patients undergoing transcatheter aortic valve replacement:the PROTAVI-C pilot study[J].JACC Cardiovasc Interv,2014,7(10):1146-1155.DOI:10.1016/j.jcin.2014.04.019.
• [48]Danenberg H,Vaknin-Assa H,Makkar R,et al.Firstin-human study of the CAPTIS embolic protection system during transcatheter aortic valve replacement[J].Euro Intervention,2023,19(11):e948-e952.DOI:10.4244/EIJ-D-23-00465.